Prepregnancy weight loss and maternal metabolic and inflammatory biomarkers during pregnancy: An analysis of National Health and Nutrition Examination Survey

Yang Yu,Qianheng Ma,Susan Groth
DOI: https://doi.org/10.1111/jog.15904
2024-02-19
Journal of Obstetrics and Gynaecology Research
Abstract:Aim Women with overweight or obesity are recommended to lose weight before conception to optimize pregnancy outcomes. However, the obstetrical implications of prepregnancy weight loss have been minimally examined. The objective of this study was to investigate the association between prepregnancy weight loss and maternal metabolic and inflammatory profiles during a subsequent pregnancy. Methods This study was a retrospective analysis of National Health and Nutrition Examination Survey data (2003–2018). Participants were women who were pregnant at the time of assessment. Prepregnancy weight loss was described as percent weight change based on self‐reported baseline (1 year before pregnancy) and prepregnancy weight. Metabolic (e.g., blood pressure [BP]) and inflammatory biomarkers (i.e., high‐sensitivity C‐reactive protein [hs‐CRP]) were determined by standard medical tests. Statistical analyses included linear regressions with appropriate imputation, weighting, and variance estimation techniques. Results Participants (N = 236) reported a mean percent weight loss of 4.6% (standard error [SE] = 0.3%) during the year before pregnancy. Regression models showed that prepregnancy weight loss was inversely associated with levels of total cholesterol (β = −1.24, p = 0.01), low‐density lipoprotein‐cholesterol (β = −0.79, p
obstetrics & gynecology
What problem does this paper attempt to address?